• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

输注血小板后 24 小时内校正血小板计数增加值呈线性下降:一项前瞻性观察研究。

Linear decline of corrected platelet count increment within 24 hours after platelet transfusion in haematological patients: A prospective observational study.

机构信息

Department of Clinical Sciences, Lund University, Lund, Sweden.

Department of Intensive and Perioperative Care, Skåne University Hospital in Lund, Lund, Sweden.

出版信息

Eur J Haematol. 2017 Dec;99(6):559-568. doi: 10.1111/ejh.12974. Epub 2017 Oct 16.

DOI:10.1111/ejh.12974
PMID:28952164
Abstract

OBJECTIVES

The aim of this study was to prospectively explore the detailed longitudinal development of platelet increments in patients with chemotherapy-induced bone marrow aplasia during the first 24 hours after platelet transfusion.

METHODS

Patients admitted to the Haematology department during 7 months, and fulfilled inclusion criteria were divided into 4 groups: Group 1, patients with acute leukaemia; Group 2, patients after autologous stem cell transplantation (SCT); Group 3, patients after allogeneic SCT; and Group 4, patients given platelet transfusion prior to intervention. We used frequent blood sampling within 24 hours after platelet transfusion to investigate the kinetics of platelet counts following transfusion.

RESULTS AND CONCLUSIONS

Fifty-four platelet transfusion occasions in patients with chemotherapy-induced bone marrow aplasia were included. The decrease in corrected count increment (CCI) 1-24 hours after platelet transfusions in all groups could be described as linear functions. For patients in the aggregated Groups 1-3, the decline was 2.0% ± 0.6% (mean ± standard deviation) per hour. For patients in Group 4, the decline of CCI was 2.8% ± 1.2% per hour. We found no differences between the groups, either in the rate of platelet elimination from the bloodstream or in the mean CCI, in the first 24 hours post-transfusion.

摘要

目的

本研究旨在前瞻性地探讨化疗诱导的骨髓衰竭患者在血小板输注后 24 小时内血小板增加的详细纵向发展。

方法

7 个月内入住血液科并符合纳入标准的患者分为 4 组:组 1,急性白血病患者;组 2,自体干细胞移植(SCT)后患者;组 3,异基因 SCT 后患者;组 4,干预前给予血小板输注的患者。我们在血小板输注后 24 小时内频繁采血,以研究输注后血小板计数的动力学。

结果和结论

共纳入 54 例化疗诱导的骨髓衰竭患者的血小板输注。所有组 1-24 小时校正计数增加(CCI)的减少可描述为线性函数。对于聚集的组 1-3 中的患者,输注后每小时下降 2.0%±0.6%(平均值±标准差)。对于组 4 的患者,CCI 的下降速度为每小时 2.8%±1.2%。我们发现,在输注后 24 小时内,无论是从血液中清除血小板的速度还是平均 CCI,各组之间均无差异。

相似文献

1
Linear decline of corrected platelet count increment within 24 hours after platelet transfusion in haematological patients: A prospective observational study.输注血小板后 24 小时内校正血小板计数增加值呈线性下降:一项前瞻性观察研究。
Eur J Haematol. 2017 Dec;99(6):559-568. doi: 10.1111/ejh.12974. Epub 2017 Oct 16.
2
Determination viability of a transfused platelet product by corrected count increment and percentage platelet response.通过校正计数增加值和血小板反应百分比来确定输注血小板产品的活力。
Pan Afr Med J. 2017 Jul 28;27:226. doi: 10.11604/pamj.2017.27.226.12116. eCollection 2017.
3
Platelet increment is not associated with endothelial damage in haematological patients: a prospective observational study.血小板增加与血液学患者的内皮损伤无关:一项前瞻性观察研究。
Scand J Clin Lab Invest. 2019 Oct;79(6):395-403. doi: 10.1080/00365513.2019.1636403. Epub 2019 Jul 5.
4
Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation--a prospective analysis.影响造血干细胞移植患者输血后血小板增量的临床因素——一项前瞻性分析。
Transfusion. 1998 Sep;38(9):839-47. doi: 10.1046/j.1537-2995.1998.38998409004.x.
5
Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions.在添加溶液中用核黄素病原体灭活技术处理的血小板输注后校正计数增加值的观察性研究。
Transfusion. 2015 Jul;55(7):1745-51. doi: 10.1111/trf.13026. Epub 2015 Feb 23.
6
Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.输注重组人血小板生成素来源的自体冻存血小板以支持化疗相关严重血小板减少症的安全性和有效性:一项随机交叉研究。
Lancet. 2002 Jun 22;359(9324):2145-52. doi: 10.1016/S0140-6736(02)09090-6.
7
Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.接受大剂量化疗和循环祖细胞移植的II/III期乳腺癌患者的自体血小板输注
Haematologica. 1998 Aug;83(8):718-23.
8
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.治疗性血小板输注与血液病患者常规预防性血小板输注的比较:一项开放标签、多中心、随机研究。
Lancet. 2012 Oct 13;380(9850):1309-16. doi: 10.1016/S0140-6736(12)60689-8. Epub 2012 Aug 8.
9
Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.单采单供者血小板与混合血小板浓缩物预防性输血在接受异基因造血干细胞移植的急性髓系白血病/骨髓增生异常综合征患者中的疗效
Bone Marrow Transplant. 2007 Sep;40(5):461-4. doi: 10.1038/sj.bmt.1705751. Epub 2007 Jun 25.
10
Plasma thrombopoietin concentrations in response to platelet transfusion therapy.血小板输注治疗后血浆血小板生成素浓度
Acta Haematol. 2000;102(3):131-4. doi: 10.1159/000040986.

引用本文的文献

1
Platelet transfusions in adult ICU patients with thrombocytopenia: A sub-study of the PLOT-ICU inception cohort study.成人 ICU 血小板减少症患者的血小板输注:PLOT-ICU 起始队列研究的子研究。
Acta Anaesthesiol Scand. 2024 Sep;68(8):1018-1030. doi: 10.1111/aas.14467. Epub 2024 Jun 5.
2
Platelet transfusions in adult thrombocytopenic ICU patients: Protocol for a sub-study of the PLOT-ICU cohort.成人血小板减少性 ICU 患者的血小板输注:PLOT-ICU 队列研究的子研究方案。
Acta Anaesthesiol Scand. 2024 Mar;68(3):434-440. doi: 10.1111/aas.14365. Epub 2023 Dec 19.
3
Prophylactic platelet transfusion response in critically ill patients: a prospective multicentre observational study.
危重症患者预防性血小板输注反应:一项前瞻性多中心观察性研究。
Crit Care. 2023 Sep 27;27(1):373. doi: 10.1186/s13054-023-04650-z.
4
The Dynamics of Circulating Heparin-Binding Protein: Implications for Its Use as a Biomarker.循环肝素结合蛋白的动力学:对其作为生物标志物的应用的启示。
J Innate Immun. 2022;14(5):447-460. doi: 10.1159/000521064. Epub 2021 Dec 29.